Masuyama H - Search Results

1

The adenosine deaminase family acting on RNA 1 can be a useful diagnostic biomarker in chorioamnionitis.

Nakamura K, Shigeyasu K, Maki J, Eto E, Masuyama H. Nakamura K, et al. Among authors: masuyama h. Placenta. 2024 Aug;153:53-58. doi: 10.1016/j.placenta.2024.05.133. Epub 2024 May 23. Placenta. 2024. PMID: 38820942

2

The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer.

Nishida T, Nakamura K, Haraga J, Ogawa C, Kusumoto T, Seki N, Masuyama H, Katayama N, Kanazawa S, Hiramatsu Y. Nishida T, et al. Among authors: masuyama h. Int J Gynecol Cancer. 2015 Sep;25(7):1306-14. doi: 10.1097/IGC.0000000000000485. Int J Gynecol Cancer. 2015. PMID: 26067860

3

Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.

Sawada M, Masuyama H, Hayata K, Kamada Y, Nakamura K, Hiramatsu Y. Sawada M, et al. Among authors: masuyama h. Endocr J. 2015;62(11):1017-23. doi: 10.1507/endocrj.EJ15-0364. Epub 2015 Sep 11. Endocr J. 2015. PMID: 26370557 Free article.

4

Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy.

Nakamura K, Nishida T, Haruma T, Haraga J, Omichi C, Ogawa C, Kusumoto T, Seki N, Masuyama H, Hiramatsu Y. Nakamura K, et al. Among authors: masuyama h. Mol Clin Oncol. 2015 Sep;3(5):1001-1006. doi: 10.3892/mco.2015.595. Epub 2015 Jul 1. Mol Clin Oncol. 2015. PMID: 26623040 Free PMC article.

5

Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.

Omichi C, Nakamura K, Haraga J, Masuyama H, Hiramatsu Y. Omichi C, et al. Among authors: masuyama h. Cancer Med. 2016 Jun;5(6):1074-80. doi: 10.1002/cam4.681. Epub 2016 Mar 1. Cancer Med. 2016. PMID: 26929186 Free PMC article.

6

Three histologically distinct cancers of the uterine corpus: A case report and review of the literature.

Masuyama H, Haraga J, Nishida T, Ogawa C, Kusumoto T, Nakamura K, Seki N, Yanai H, Hiramatsu Y. Masuyama H, et al. Mol Clin Oncol. 2016 Apr;4(4):563-566. doi: 10.3892/mco.2016.770. Epub 2016 Feb 5. Mol Clin Oncol. 2016. PMID: 27073663 Free PMC article.

7

Differences in uterine artery blood flow and fetal growth between the early and late onset of pregnancy-induced hypertension.

Mitsui T, Masuyama H, Maki J, Tamada S, Hirano Y, Eto E, Nobumoto E, Hayata K, Hiramatsu Y. Mitsui T, et al. Among authors: masuyama h. J Med Ultrason (2001). 2016 Oct;43(4):509-17. doi: 10.1007/s10396-016-0729-6. Epub 2016 Jun 28. J Med Ultrason (2001). 2016. PMID: 27352079

8

Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high-fat diet-fed pregnant mice via constitutive androstane receptor.

Masuyama H, Mitsui T, Maki J, Tani K, Nakamura K, Hiramatsu Y. Masuyama H, et al. Mol Cell Biochem. 2016 Aug;419(1-2):185-92. doi: 10.1007/s11010-016-2772-4. Epub 2016 Jul 18. Mol Cell Biochem. 2016. PMID: 27426490

9

Return to work after cancer treatment of gynecologic cancer in Japan.

Nakamura K, Masuyama H, Nishida T, Haraga J, Ida N, Saijo M, Haruma T, Kusumoto T, Seki N, Hiramatsu Y. Nakamura K, et al. Among authors: masuyama h. BMC Cancer. 2016 Jul 29;16:558. doi: 10.1186/s12885-016-2627-0. BMC Cancer. 2016. PMID: 27473230 Free PMC article.

10

Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.

Masuyama H, Nakamura K, Nobumoto E, Hiramatsu Y. Masuyama H, et al. Int J Oncol. 2016 Sep;49(3):1211-20. doi: 10.3892/ijo.2016.3611. Epub 2016 Jul 6. Int J Oncol. 2016. PMID: 27572875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters